产品中心 / 产品类型 / 重组蛋白 / 生物标志物 & CD分子

Recombinant Human TIE2/TEK/CD202b Protein (RP00048)

Recombinant Human TIE2/TEK/CD202b Protein was determined by SDS-PAGE with Coomassie Blue, showing a band at 35 kDa.

Immobilized Human hTIE2 at 2 μg/mL (100 μL/well) can bind TEK Rabbit pAb with a linear range of 1.406-458.65 ng/mL.

Immobilized recombinant Human TEK Protein at 2 μg/mL (100 μL/well) can bind ANG2 with a linear range of 39-7090ng/mL.

All(3)|
货号: RP00048
促销价:   ¥620
货    期:现货产品
抗体定制服务咨询

文献引用 (0)

详细信息

种属
Human
表达宿主
Baculovirus-Infected Sf9 Cells
描述
Recombinant Human TIE2/TEK/CD202b Protein is produced by insect cell-baculovirus expression system. The target protein is expressed with sequence (Lys808-Ala1124) of human hTIE2 (Accession #NP_000450.2).
标签
No tag
纯度
> 97% by SDS-PAGE.
内毒素
< 1.0 EU/μg of the protein by LAL method.
生物活性
Measured by its binding ability in a functional ELISA. Immobilized Human TEK Protein at 2 μg/mL (100 μL/well) can bind ANG2 with a linear range of 39-7090 ng/mL.
制剂
Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.
储存
Store the lyophilized protein at -20°C to -80 °C for long term.
After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.未开盖的干粉蛋白在 -20°C至-80°C可保存12个月;
复溶之后,蛋白溶液在-20°C及以下可保存3个月,在2-8℃可保存1周。
复溶
Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid votex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.收到重组蛋白产品之后请检查蛋白冻干粉末是否贴于瓶底,如果粉末浮起,开盖之前请先低温离心。将蛋白用说明书中指定的缓冲液复溶至0.1-0.5 mg/mL(请注意蛋白复溶浓度不能低于0.1 mg/mL),室温平衡5-10 min保证充分溶解,复溶过程中请不要剧烈涡旋及吹打蛋白溶液。如需长期储存,建议复溶时添加载体蛋白或者稳定剂(如0.1% BSA, 5% HSA, 10% FBS 或者 5% 海藻糖),同时将复溶后的蛋白溶液按照需求进行分装,储存于-20°C至-80°C,随取随用,避免反复冻融。

蛋白复溶计算器

请在蛋白复溶计算器中输入蛋白总质量和所需终浓度,快速计算您需要添加溶液的体积吧!
=
÷

背景信息

Tyrosine-protein kinase that acts as cell-surface receptor for ANGPT1, ANGPT2 and ANGPT4 and regulates angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Has anti-inflammatory effects by preventing the leakage of proinflammatory plasma proteins and leukocytes from blood vessels. Required for normal angiogenesis and heart development during embryogenesis. Required for post-natal hematopoiesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts.

>